[Use of recombinant protein E2 of the classical swine fever virus for immunization of animals]

Vopr Virusol. 2000 Mar-Apr;45(2):36-41.
[Article in Russian]

Abstract

Recombinant major surface glycoprotein E2 from virulent Shimen strain of classical swine fever virus (CSFV) has been tested for immunogenicity in animal immunization experiments. Immunization of 3-month-old piglets with 200 micrograms of recombinant protein protected the animals from lethal challenge with virulent CSFV strain. CSFV-specific antibody detection test based on competitive ELISA has been developed using the recombinant E2 protein. The test can evaluate specific antibody levels after subunit vaccination with recombinant E2 after immunization with live vaccine based on attenuated CSFV strain.

Publication types

  • English Abstract

MeSH terms

  • Animals
  • Antibodies, Viral / blood
  • Chromatography, Affinity
  • Classical Swine Fever / prevention & control*
  • Enzyme-Linked Immunosorbent Assay
  • Recombinant Proteins / administration & dosage*
  • Recombinant Proteins / immunology
  • Recombinant Proteins / isolation & purification
  • Swine
  • Viral Envelope Proteins / administration & dosage*
  • Viral Envelope Proteins / immunology
  • Viral Envelope Proteins / isolation & purification
  • Viral Vaccines / administration & dosage*
  • Viral Vaccines / immunology

Substances

  • Antibodies, Viral
  • Recombinant Proteins
  • Viral Envelope Proteins
  • Viral Vaccines
  • glycoprotein E2, classical swine fever virus